{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:13:05Z","timestamp":1780603985491,"version":"3.54.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19dm0107103"],"award-info":[{"award-number":["19dm0107103"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21ek0109486"],"award-info":[{"award-number":["JP21ek0109486"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21ek0109549"],"award-info":[{"award-number":["JP21ek0109549"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21cm0106503"],"award-info":[{"award-number":["JP21cm0106503"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21ek0109493"],"award-info":[{"award-number":["JP21ek0109493"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["17H01564"],"award-info":[{"award-number":["17H01564"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["17KT0131"],"award-info":[{"award-number":["17KT0131"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["JP20K17936"],"award-info":[{"award-number":["JP20K17936"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["16H06277"],"award-info":[{"award-number":["16H06277"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neuronal intranuclear inclusion disease (NIID) is a neurodegenerative disorder, characterized by the presence of eosinophilic inclusions (NIIs) within nuclei of central and peripheral nervous system cells. This study aims to identify the components of NIIs, which have been difficult to analyze directly due to their insolubility. In order to establish a method to directly identify the components of NIIs, we first analyzed the huntingtin inclusion-rich fraction obtained from the brains of Huntington disease model mice. Although the sequence with expanded polyglutamine could not be identified by liquid-chromatography mass spectrometry, amino acid analysis revealed that glutamine of the huntingtin inclusion-rich fraction increased significantly. This is compatible with the calculated amino acid content of the transgene product. Therefore, we applied this method to analyze the NIIs of diseased human brains, which may have proteins with compositionally biased regions, and identified a serine-rich protein called hornerin. Since the analyzed NII-rich fraction was also serine-rich, we suggested hornerin as a major component of the NIIs. A specific distribution of hornerin in NIID was also investigated by Matrix-assisted laser desorption\/ionization imaging mass spectrometry and immunofluorescence. Finally, we confirmed a variant of hornerin by whole-exome sequencing and DNA sequencing. This study suggests that hornerin may be related to the pathological process of this NIID, and the direct analysis of NIIs, especially by amino acid analysis using the NII-rich fractions, would contribute to a deeper understanding of the disease pathogenesis.<\/jats:p>","DOI":"10.1186\/s40478-022-01333-8","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T06:02:49Z","timestamp":1646373769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hornerin deposits in neuronal intranuclear inclusion disease: direct identification of proteins with compositionally biased regions in inclusions"],"prefix":"10.1186","volume":"10","author":[{"given":"Hongsun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nirasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomichi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Shimogori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Ikegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti J.","family":"Haltia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4545-5100","authenticated-orcid":false,"given":"Nobuyuki","family":"Nukina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"issue":"1","key":"1333_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/BF00690510","volume":"10","author":"R Lindenberg","year":"1968","unstructured":"Lindenberg R, Rubinstein LJ, Herman MM, Haydon GB (1968) A light and electron microscopy study of an unusual widespread nuclear inclusion body disease. A possible residuum of an old herpesvirus infection. Acta Neuropathol 10(1):54\u201373","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1333_CR2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/ana.410150403","volume":"15","author":"M Haltia","year":"1984","unstructured":"Haltia M, Somer H, Palo J, Johnson WG (1984) Neuronal intranuclear inclusion disease in identical twins. Ann Neurol 15(4):316\u2013321","journal-title":"Ann Neurol"},{"issue":"2","key":"1333_CR3","first-page":"93","volume":"14","author":"KM Weidenheim","year":"1995","unstructured":"Weidenheim KM, Dickson DW (1995) Intranuclear inclusion bodies in an elderly demented woman: a form of intranuclear inclusion body disease. Clin Neuropathol 14(2):93\u201399","journal-title":"Clin Neuropathol"},{"issue":"4","key":"1333_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1046\/j.1440-1789.2003.00524.x","volume":"23","author":"J Takahashi-Fujigasaki","year":"2003","unstructured":"Takahashi-Fujigasaki J (2003) Neuronal intranuclear hyaline inclusion disease. Neuropathology 23(4):351\u2013359","journal-title":"Neuropathology"},{"issue":"Pt 12","key":"1333_CR5","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1093\/brain\/aww249","volume":"139","author":"J Sone","year":"2016","unstructured":"Sone J, Mori K, Inagaki T, Katsumata R, Takagi S, Yokoi S et al (2016) Clinicopathological features of adult-onset neuronal intranuclear inclusion disease. Brain 139(Pt 12):3170\u20133186","journal-title":"Brain"},{"issue":"9","key":"1333_CR6","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1002\/acn3.51151","volume":"7","author":"Z Chen","year":"2020","unstructured":"Chen Z, Yan Yau W, Jaunmuktane Z, Tucci A, Sivakumar P, Gagliano Taliun SA et al (2020) Neuronal intranuclear inclusion disease is genetically heterogeneous. Ann Clin Transl Neurol 7(9):1716\u20131725","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"1333_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1365-2990.2005.00705.x","volume":"32","author":"J Takahashi-Fujigasaki","year":"2006","unstructured":"Takahashi-Fujigasaki J, Arai K, Funata N, Fujigasaki H (2006) SUMOylation substrates in neuronal intranuclear inclusion disease. Neuropathol Appl Neurobiol 32(1):92\u2013100","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"9096","key":"1333_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0140-6736(97)08360-8","volume":"351","author":"SW Davies","year":"1998","unstructured":"Davies SW, Beardsall K, Turmaine M, DiFiglia M, Aronin N, Bates GP (1998) Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions? Lancet 351(9096):131\u2013133","journal-title":"Lancet"},{"key":"1333_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-pathmechdis-012418-012857","volume":"14","author":"AP Lieberman","year":"2019","unstructured":"Lieberman AP, Shakkottai VG, Albin RL (2019) Polyglutamine repeats in neurodegenerative diseases. Annu Rev Pathol 14:1\u201327","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"1333_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nrm3920","volume":"16","author":"PE Wright","year":"2015","unstructured":"Wright PE, Dyson HJ (2015) Intrinsically disordered proteins in cellular signalling and regulation. Nat Rev Mol Cell Biol 16(1):18\u201329","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1333_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-015-0125-7","volume":"14","author":"DM Mitrea","year":"2016","unstructured":"Mitrea DM, Kriwacki RW (2016) Phase separation in biology; functional organization of a higher order. Cell Commun Signal 14:1","journal-title":"Cell Commun Signal"},{"issue":"1","key":"1333_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1073\/pnas.1013343108","volume":"108","author":"T Zu","year":"2011","unstructured":"Zu T, Gibbens B, Doty NS, Gomes-Pereira M, Huguet A, Stone MD et al (2011) Non-ATG-initiated translation directed by microsatellite expansions. Proc Natl Acad Sci U S A 108(1):260\u2013265","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"1333_CR13","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1212\/WNL.0b013e3182166e13","volume":"76","author":"J Sone","year":"2011","unstructured":"Sone J, Tanaka F, Koike H, Inukai A, Katsuno M, Yoshida M et al (2011) Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease. Neurology 76(16):1372\u20131376","journal-title":"Neurology"},{"issue":"8","key":"1333_CR14","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/s41588-019-0459-y","volume":"51","author":"J Sone","year":"2019","unstructured":"Sone J, Mitsuhashi S, Fujita A, Mizuguchi T, Hamanaka K, Mori K et al (2019) Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease. Nat Genet 51(8):1215\u20131221","journal-title":"Nat Genet"},{"issue":"8","key":"1333_CR15","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/s41588-019-0458-z","volume":"51","author":"H Ishiura","year":"2019","unstructured":"Ishiura H, Shibata S, Yoshimura J, Suzuki Y, Qu W, Doi K et al (2019) Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease. Nat Genet 51(8):1222\u20131232","journal-title":"Nat Genet"},{"issue":"6","key":"1333_CR16","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/brain\/awab077","volume":"144","author":"J Yu","year":"2021","unstructured":"Yu J, Deng J, Guo X, Shan J, Luan X, Cao L et al (2021) The GGC repeat expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy type 3. Brain 144(6):1819\u20131832","journal-title":"Brain"},{"issue":"11","key":"1333_CR17","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.neuron.2021.03.038","volume":"109","author":"M Boivin","year":"2021","unstructured":"Boivin M, Deng J, Pfister V, Grandgirard E, Oulad-Abdelghani M, Morlet B et al (2021) Translation of GGC repeat expansions into a toxic polyglycine protein in NIID defines a novel class of human genetic disorders: The polyG diseases. Neuron 109(11):1825\u201335.e5","journal-title":"Neuron"},{"issue":"10","key":"1333_CR18","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/jnen\/nlaa070","volume":"79","author":"I Jedlickova","year":"2020","unstructured":"Jedlickova I, Pristoupilova A, Hulkova H, Vrbacka A, Stranecky V, Hruba E et al (2020) NOTCH2NLC CGG repeats are not expanded and skin biopsy was negative in an infantile patient with neuronal intranuclear inclusion disease. J Neuropathol Exp Neurol 79(10):1065\u20131071","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"1333_CR19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1471-4159.2005.03035.x","volume":"93","author":"S Kotliarova","year":"2005","unstructured":"Kotliarova S, Jana NR, Sakamoto N, Kurosawa M, Miyazaki H, Nekooki M et al (2005) Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates. J Neurochem 93(3):641\u2013653","journal-title":"J Neurochem"},{"issue":"5","key":"1333_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wisniewski","year":"2009","unstructured":"Wisniewski JR, Zougman A, Nagaraj N, Mann M (2009) Universal sample preparation method for proteome analysis. Nat Methods 6(5):359\u2013362","journal-title":"Nat Methods"},{"issue":"4","key":"1333_CR21","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1021\/pr501045t","volume":"14","author":"T Shalit","year":"2015","unstructured":"Shalit T, Elinger D, Savidor A, Gabashvili A, Levin Y (2015) MS1-based label-free proteomics using a quadrupole orbitrap mass spectrometer. J Proteome Res 14(4):1979\u20131986","journal-title":"J Proteome Res"},{"key":"1333_CR22","first-page":"e57645","volume":"145","author":"M Ikegawa","year":"2019","unstructured":"Ikegawa M, Nirasawa T, Kakuda N, Miyasaka T, Kuzuhara Y, Murayama S et al (2019) Visualization of amyloid beta deposits in the human brain with matrix-assisted laser desorption\/ionization imaging mass spectrometry. J Vis Exp 145:e57645","journal-title":"J Vis Exp"},{"issue":"4","key":"1333_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s10038-017-0408-5","volume":"63","author":"H Doi","year":"2018","unstructured":"Doi H, Koyano S, Miyatake S, Nakajima S, Nakazawa Y, Kunii M et al (2018) Cerebellar ataxia-dominant phenotype in patients with ERCC4 mutations. J Hum Genet 63(4):417\u2013423","journal-title":"J Hum Genet"},{"issue":"4","key":"1333_CR24","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1093\/nar\/gkx1266","volume":"46","author":"MC Frith","year":"2018","unstructured":"Frith MC, Khan S (2018) A survey of localized sequence rearrangements in human DNA. Nucleic Acids Res 46(4):1661\u20131673","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1333_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13059-019-1667-6","volume":"20","author":"S Mitsuhashi","year":"2019","unstructured":"Mitsuhashi S, Frith MC, Mizuguchi T, Miyatake S, Toyota T, Adachi H et al (2019) Tandem-genotypes: robust detection of tandem repeat expansions from long DNA reads. Genome Biol 20(1):58","journal-title":"Genome Biol"},{"issue":"2","key":"1333_CR26","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1471-4159.2006.03893.x","volume":"98","author":"F Oyama","year":"2006","unstructured":"Oyama F, Miyazaki H, Sakamoto N, Becquet C, Machida Y, Kaneko K et al (2006) Sodium channel beta4 subunit: down-regulation and possible involvement in neuritic degeneration in Huntington\u2019s disease transgenic mice. J Neurochem 98(2):518\u2013529","journal-title":"J Neurochem"},{"key":"1333_CR27","doi-asserted-by":"publisher","first-page":"35236","DOI":"10.1038\/srep35236","volume":"6","author":"Y Kino","year":"2016","unstructured":"Kino Y, Washizu C, Kurosawa M, Yamada M, Doi H, Takumi T et al (2016) FUS\/TLS acts as an aggregation-dependent modifier of polyglutamine disease model mice. Sci Rep 6:35236","journal-title":"Sci Rep"},{"issue":"6","key":"1333_CR28","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/0896-6273(93)90063-W","volume":"10","author":"M Morishima-Kawashima","year":"1993","unstructured":"Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Titani K, Ihara Y (1993) Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron 10(6):1151\u20131160","journal-title":"Neuron"},{"issue":"5","key":"1333_CR29","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1440-1789.2007.00803.x","volume":"27","author":"K Wakabayashi","year":"2007","unstructured":"Wakabayashi K, Tanji K, Mori F, Takahashi H (2007) The Lewy body in Parkinson\u2019s disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology 27(5):494\u2013506","journal-title":"Neuropathology"},{"issue":"5667","key":"1333_CR30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1126\/science.1092194","volume":"304","author":"JS Steffan","year":"2004","unstructured":"Steffan JS, Agrawal N, Pallos J, Rockabrand E, Trotman LC, Slepko N et al (2004) SUMO modification of Huntingtin and Huntington\u2019s disease pathology. Science 304(5667):100\u2013104","journal-title":"Science"},{"issue":"4","key":"1333_CR31","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2017.09.040","volume":"171","author":"RG Yau","year":"2017","unstructured":"Yau RG, Doerner K, Castellanos ER, Haakonsen DL, Werner A, Wang N et al (2017) Assembly and function of heterotypic ubiquitin chains in cell-cycle and protein quality control. Cell 171(4):918\u201333.e20","journal-title":"Cell"},{"issue":"31","key":"1333_CR32","doi-asserted-by":"publisher","first-page":"18661","DOI":"10.1073\/pnas.2007667117","volume":"117","author":"V Hakim-Eshed","year":"2020","unstructured":"Hakim-Eshed V, Boulos A, Cohen-Rosenzweig C, Yu-Taeger L, Ziv T, Kwon YT et al (2020) Site-specific ubiquitination of pathogenic huntingtin attenuates its deleterious effects. Proc Natl Acad Sci U S A 117(31):18661\u201318669","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1333_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1699-0463.1998.tb01346.x","volume":"106","author":"A Terman","year":"1998","unstructured":"Terman A, Brunk UT (1998) Lipofuscin: mechanisms of formation and increase with age. APMIS 106(2):265\u2013276","journal-title":"APMIS"},{"issue":"5","key":"1333_CR34","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.freeradbiomed.2010.12.011","volume":"50","author":"A Hohn","year":"2011","unstructured":"Hohn A, Jung T, Grimm S, Catalgol B, Weber D, Grune T (2011) Lipofuscin inhibits the proteasome by binding to surface motifs. Free Radic Biol Med 50(5):585\u2013591","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1333_CR35","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1038\/s41598-019-40250-0","volume":"9","author":"Y Kakimoto","year":"2019","unstructured":"Kakimoto Y, Okada C, Kawabe N, Sasaki A, Tsukamoto H, Nagao R et al (2019) Myocardial lipofuscin accumulation in ageing and sudden cardiac death. Sci Rep 9(1):3304","journal-title":"Sci Rep"},{"issue":"1","key":"1333_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40478-017-0477-x","volume":"5","author":"N Kakuda","year":"2017","unstructured":"Kakuda N, Miyasaka T, Iwasaki N, Nirasawa T, Wada-Kakuda S, Takahashi-Fujigasaki J et al (2017) Distinct deposition of amyloid-beta species in brains with Alzheimer\u2019s disease pathology visualized with MALDI imaging mass spectrometry. Acta Neuropathol Commun 5(1):73","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"1333_CR37","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1074\/jbc.M409026200","volume":"280","author":"M Takaishi","year":"2005","unstructured":"Takaishi M, Makino T, Morohashi M, Huh NH (2005) Identification of human hornerin and its expression in regenerating and psoriatic skin. J Biol Chem 280(6):4696\u20134703","journal-title":"J Biol Chem"},{"issue":"4","key":"1333_CR38","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1177\/002215540305100410","volume":"51","author":"T Makino","year":"2003","unstructured":"Makino T, Takaishi M, Toyoda M, Morohashi M, Huh NH (2003) Expression of hornerin in stratified squamous epithelium in the mouse: a comparative analysis with profilaggrin. J Histochem Cytochem 51(4):485\u2013492","journal-title":"J Histochem Cytochem"},{"issue":"6","key":"1333_CR39","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/jid.2008.370","volume":"129","author":"Z Wu","year":"2009","unstructured":"Wu Z, Meyer-Hoffert U, Reithmayer K, Paus R, Hansmann B, He Y et al (2009) Highly complex peptide aggregates of the S100 fused-type protein hornerin are present in human skin. J Invest Dermatol 129(6):1446\u20131458","journal-title":"J Invest Dermatol"},{"key":"1333_CR40","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/1471-2407-12-266","volume":"12","author":"JM Fleming","year":"2012","unstructured":"Fleming JM, Ginsburg E, Oliver SD, Goldsmith P, Vonderhaar BK (2012) Hornerin, an S100 family protein, is functional in breast cells and aberrantly expressed in breast cancer. BMC Cancer 12:266","journal-title":"BMC Cancer"},{"issue":"2","key":"1333_CR41","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4048\/jbc.2016.19.2.142","volume":"19","author":"J Choi","year":"2016","unstructured":"Choi J, Kim DI, Kim J, Kim BH, Kim A (2016) Hornerin Is Involved in Breast Cancer Progression. J Breast Cancer 19(2):142\u2013147","journal-title":"J Breast Cancer"},{"issue":"1","key":"1333_CR42","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1186\/s12885-018-4719-5","volume":"18","author":"SJ Fu","year":"2018","unstructured":"Fu SJ, Shen SL, Li SQ, Hua YP, Hu WJ, Guo B et al (2018) Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma. BMC Cancer 18(1):815","journal-title":"BMC Cancer"},{"issue":"1","key":"1333_CR43","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41467-017-00488-6","volume":"8","author":"MF Gutknecht","year":"2017","unstructured":"Gutknecht MF, Seaman ME, Ning B, Cornejo DA, Mugler E, Antkowiak PF et al (2017) Identification of the S100 fused-type protein hornerin as a regulator of tumor vascularity. Nat Commun 8(1):552","journal-title":"Nat Commun"},{"issue":"1","key":"1333_CR44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3","volume":"42","author":"P Romero","year":"2001","unstructured":"Romero P, Obradovic Z, Li X, Garner EC, Brown CJ, Dunker AK (2001) Sequence complexity of disordered protein. Proteins 42(1):38\u201348","journal-title":"Proteins"},{"issue":"3","key":"1333_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrm1589","volume":"6","author":"HJ Dyson","year":"2005","unstructured":"Dyson HJ, Wright PE (2005) Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol 6(3):197\u2013208","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"42","key":"1333_CR46","doi-asserted-by":"publisher","first-page":"16127","DOI":"10.1074\/jbc.R118.003237","volume":"293","author":"JD Cleary","year":"2018","unstructured":"Cleary JD, Pattamatta A, Ranum LPW (2018) Repeat-associated non-ATG (RAN) translation. J Biol Chem 293(42):16127\u201316141","journal-title":"J Biol Chem"},{"issue":"25","key":"1333_CR47","doi-asserted-by":"publisher","first-page":"10171","DOI":"10.1073\/pnas.0900604106","volume":"106","author":"S Kosugi","year":"2009","unstructured":"Kosugi S, Hasebe M, Tomita M, Yanagawa H (2009) Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs. Proc Natl Acad Sci U S A 106(25):10171\u201310176","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1333_CR48","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/1471-2105-10-202","volume":"10","author":"AN Nguyen Ba","year":"2009","unstructured":"Nguyen Ba AN, Pogoutse A, Provart N, Moses AM (2009) NLStradamus: a simple Hidden Markov Model for nuclear localization signal prediction. BMC Bioinformatics 10:202","journal-title":"BMC Bioinformatics"},{"issue":"10","key":"1333_CR49","doi-asserted-by":"publisher","first-page":"e76864","DOI":"10.1371\/journal.pone.0076864","volume":"8","author":"JR Lin","year":"2013","unstructured":"Lin JR, Hu J (2013) SeqNLS: nuclear localization signal prediction based on frequent pattern mining and linear motif scoring. PLoS ONE 8(10):e76864","journal-title":"PLoS ONE"},{"issue":"3","key":"1333_CR50","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1046\/j.1523-1747.2002.01831.x","volume":"119","author":"DJ Pearton","year":"2002","unstructured":"Pearton DJ, Dale BA, Presland RB (2002) Functional analysis of the profilaggrin N-terminal peptide: identification of domains that regulate nuclear and cytoplasmic distribution. J Invest Dermatol 119(3):661\u2013669","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1333_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12964-021-00741-y","volume":"19","author":"J Lu","year":"2021","unstructured":"Lu J, Wu T, Zhang B, Liu S, Song W, Qiao J et al (2021) Types of nuclear localization signals and mechanisms of protein import into the nucleus. Cell Commun Signal 19(1):60","journal-title":"Cell Commun Signal"},{"issue":"5","key":"1333_CR52","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1021\/pr060392u","volume":"6","author":"H Xie","year":"2007","unstructured":"Xie H, Vucetic S, Iakoucheva LM, Oldfield CJ, Dunker AK, Uversky VN et al (2007) Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions. J Proteome Res 6(5):1882\u20131898","journal-title":"J Proteome Res"},{"issue":"D1","key":"1333_CR53","doi-asserted-by":"publisher","first-page":"D435","DOI":"10.1093\/nar\/gkv1240","volume":"44","author":"KY Huang","year":"2016","unstructured":"Huang KY, Su MG, Kao HJ, Hsieh YC, Jhong JH, Cheng KH et al (2016) dbPTM 2016: 10-year anniversary of a resource for post-translational modification of proteins. Nucleic Acids Res 44(D1):D435\u2013D446","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"1333_CR54","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/pmic.201200452","volume":"13","author":"L Kollipara","year":"2013","unstructured":"Kollipara L, Zahedi RP (2013) Protein carbamylation: in vivo modification or in vitro artefact? Proteomics 13(6):941\u2013944","journal-title":"Proteomics"},{"issue":"5","key":"1333_CR55","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1212\/01.WNL.0000169023.51764.b0","volume":"65","author":"M Farrer","year":"2005","unstructured":"Farrer M, Stone J, Mata IF, Lincoln S, Kachergus J, Hulihan M et al (2005) LRRK2 mutations in Parkinson disease. Neurology 65(5):738\u2013740","journal-title":"Neurology"},{"issue":"7809","key":"1333_CR56","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alfoldi J, Wang Q et al (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581(7809):434\u2013443","journal-title":"Nature"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01333-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01333-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01333-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T10:12:50Z","timestamp":1666519970000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01333-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1333"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01333-8","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"21 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}